News
Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
CARLSBAD, Calif., Sept. 20, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in...
Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
Company reports highest quarterly revenue in Company's history of $4.1 million, 68% year over year increase and 15% sequential growth from Q1Management to host conference call today, August 29, 2022 at 11:00 AM ET CARLSBAD, Calif. , Aug. 29, 2022 -- Aurora Spine...
Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call
CARLSBAD, Calif., Aug. 22, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial...
Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants
CARLSBAD, Calif., July 12, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication for Use for its...
Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion
CARLSBAD, Calif., June 13, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States...
Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform
CARLSBAD, Calif, June 06, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it had received FDA 510(k)...
Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results
Company reports highest quarterly revenue in Company's history of $3.55 million, 57% year over year increase and 20% sequential growth from Q4 - Management to host conference call today, May 24, 2022 at 11:00 AM ET -NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER...
Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call
CARLSBAD, Calif., May 23, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results...
Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 -Management to host conference call on Monday, May 2, 2022 at 11:00 AM ET -...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
CARLSBAD, Calif, April 29, 2022 -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 -Management to host conference call on Monday,...